ISSN: 1300-7777 E-ISSN: 1308-5263
Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma [Turk J Hematol]
Turk J Hematol. 2014; 31(1): 92-94 | DOI: 10.4274/Tjh.2013.0180  

Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma

Itır Şirinoğlu Demiriz1, Emre Tekgündüz1, Sinem Civriz Bozdağ1, Fevzi Altuntaş2
1Ankara Oncology Hospital, Department Of Hematology And Stem Cell Transplantation Unit, Ankara, Turkey
2Ankara Oncology Education And Research Hospital, Ankara, Turkey



Yaygın Büyük B hücreli Lenfoma Tedavisi Sonrası Sekonder Malignite Olarak Kronik Myeloid Lösemi

Itır Şirinoğlu Demiriz1, Emre Tekgündüz1, Sinem Civriz Bozdağ1, Fevzi Altuntaş2
1Ankara Oncology Hospital, Department Of Hematology And Stem Cell Transplantation Unit, Ankara, Turkey
2Ankara Oncology Education And Research Hospital, Ankara, Turkey



Itır Şirinoğlu Demiriz, Emre Tekgündüz, Sinem Civriz Bozdağ, Fevzi Altuntaş. Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turk J Hematol. 2014; 31(1): 92-94

Corresponding Author: Itır Şirinoğlu Demiriz, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686